Improved survival among colon cancer patients with increased differentially expressed pathways

[1]  Robert Tibshirani,et al.  Finding consistent patterns: A nonparametric approach for identifying differential expression in RNA-Seq data , 2013, Statistical methods in medical research.

[2]  Sabine Tejpar,et al.  Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer , 2013, The Journal of pathology.

[3]  D. Burgess.  Gene expression: Colorectal cancer classifications , 2013, Nature Reviews Cancer.

[4]  Cesare Furlanello,et al.  Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review , 2012, PloS one.

[5]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[6]  Kurt Hornik,et al.  The Comprehensive R Archive Network , 2012 .

[7]  R. Wolff,et al.  A Comparison of Colon and Rectal Somatic DNA Alterations , 2009, Diseases of the colon and rectum.

[8]  A. Astolfi,et al.  Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. , 2009, Cancer treatment reviews.

[9]  M. Sułkowska,et al.  Relations of TGF‐beta1 with HIF‐1alpha, GLUT‐1 and longer survival of colorectal cancer patients , 2009, Pathology.

[10]  Robert Tibshirani,et al.  Gene Expression Profiling Predicts Survival in Conventional Renal Cell Carcinoma , 2005, PLoS medicine.

[11]  R. Wolff,et al.  Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. , 2005, Gastroenterology.

[12]  A. Sánchez-Capelo.  Dual role for TGF-β1 in apoptosis , 2005 .

[13]  T. Ørntoft,et al.  Gene expression in colorectal cancer. , 2002, Cancer research.

[14]  M. Leppert,et al.  Prognostic significance of p53 mutations in colon cancer at the population level , 2002, International journal of cancer.

[15]  M. Leppert,et al.  Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Leppert,et al.  Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. , 2000, Journal of the National Cancer Institute.

[18]  K. Anderson,et al.  Use of archival tissue in epidemiologic studies: collection procedures and assessment of potential sources of bias. , 2000, Mutation research.

[19]  J. Potter,et al.  Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA) , 1999, Cancer Causes & Control.

[20]  Chi V. Dang,et al.  c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.

[21]  J. Potter,et al.  Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States , 1997, Cancer Causes & Control.

[22]  D. Smith,et al.  Overexpression of the c-myc proto-oncogene in colorectal carcinoma is associated with a reduced mortality that is abrogated by point mutation of the p53 tumor suppressor gene. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  A. Sánchez-Capelo.  Dual role for TGF-beta1 in apoptosis. , 2005, Cytokine & growth factor reviews.

[24]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .